Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats

Explore this paper's citation graph

Summary

The data indicate that the systemic delivery of Peptide5 is unlikely to cause any off-target or adverse effects and may thus be a safe treatment option for traumatic SCI.

Type
article
Published
2017-07-19
Cited by
16
References
88
Access
Open access

Keywords

Systemic administration, Medicine, Spinal cord, Spinal cord injury, Anesthesia

References

Cited by

Related papers